Heron Therapeutics Inc vs Roundhill Russell 2000 0DTE Covered Call Strat ETF — how do they compare? Heron Therapeutics Inc trades at $0.37 (market cap $74.04M), while Roundhill Russell 2000 0DTE Covered Call Strat ETF trades at $25.96 (market cap $159.33M). The key difference: Roundhill Russell 2000 0DTE Covered Call Strat ETF is far larger — about 2.2× Heron Therapeutics Inc's market cap, and Roundhill Russell 2000 0DTE Covered Call Strat ETF is more actively traded (248,058 versus 3,668,095). Which is the better fit depends on your goals — on Pluang, investors hold Heron Therapeutics Inc for 35 Days and Roundhill Russell 2000 0DTE Covered Call Strat ETF for 53 Days on average.
| HRTX | RDTE | |
|---|---|---|
Market Cap | $74.04M | $159.33M |
Volume | 3,668,095 | 248,058 |
Sector | Health | Income / Options Overlay |
52-Week High | $1.49 | $33.66 |
52-Week Low | $0.27 | $25.96 |
Typical Hold Time | 35 Days | 53 Days |
Enterprise Value | $180.78M | — |
Signals from Pluang's Aura AI — not financial advice
HRTX trades at $0.39, up 17.58% today, with a bullish technical signal from moving averages. The company reported Q2 2026 revenue of $37.7 million but missed EPS estimates with a $0.03 loss. Despite negative profitability metrics, analyst consensus remains strongly positive with 89% buy ratings. Recent news highlights ongoing comparisons with peers and earnings performance discussions.
The outlook is mixed: strong analyst support and technical momentum suggest potential upside, but persistent losses and high valuation ratios pose significant risks. Investment opportunity hinges on revenue growth translating to profitability, while key risks include execution challenges and competitive pressures in the biotechnology sector.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Heron Therapeutics is a commercial-stage biotechnology company focused on improving patient care. It develops best-in-class medicines for pain management and cancer care to address unmet medical needs.
Read more on HRTX →RDTE is an actively managed ETF that seeks to generate income through a covered call strategy on the Russell 2000 Index. The fund primarily holds a portfolio of short-term U.S. government securities and sells 0-DTE (zero days to expiration) index call options on the Russell 2000. This highly tactical strategy aims to maximize premium capture by exploiting the high time decay of options that are expiring on the same day, which provides enhanced income but also exposes the fund to significant volatility and risks associated with daily options settlement.
Read more on RDTE →